SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-18-000382
Filing Date
2018-11-05
Accepted
2018-11-05 10:21:00
Documents
4
Period of Report
2018-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnbt110218form8k.htm 8-K 39321
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 26916
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 33897
4 EXHIBITR 99.1 ex99_1.htm EX-99.1 17427
  Complete submission text file 0001607062-18-000382.txt   118895
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 181159091
SIC: 2834 Pharmaceutical Preparations